Angela S.  Lalor net worth and biography

Angela Lalor Biography and Net Worth

SVP of Danaher
Angela S. Lalor serves as Senior Vice President - Human Resources of the Company. since April 2012. Prior to joining Danaher, Ms. Lalor served for 22 years in a series of progressively more responsible positions in the human resources department of 3M Company, a global manufacturing company, including most recently as Senior Vice President, Human Resources.

What is Angela S. Lalor's net worth?

The estimated net worth of Angela S. Lalor is at least $7.70 million as of April 23rd, 2021. Ms. Lalor owns 30,937 shares of Danaher stock worth more than $7,698,363 as of March 28th. This net worth approximation does not reflect any other investments that Ms. Lalor may own. Learn More about Angela S. Lalor's net worth.

How do I contact Angela S. Lalor?

The corporate mailing address for Ms. Lalor and other Danaher executives is 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037. Danaher can also be reached via phone at (202) 828-0850 and via email at [email protected]. Learn More on Angela S. Lalor's contact information.

Has Angela S. Lalor been buying or selling shares of Danaher?

Angela S. Lalor has not been actively trading shares of Danaher during the last quarter. Most recently, Angela S. Lalor sold 37,513 shares of the business's stock in a transaction on Monday, November 29th. The shares were sold at an average price of $327.00, for a transaction totalling $12,266,751.00. Learn More on Angela S. Lalor's trading history.

Who are Danaher's active insiders?

Danaher's insider roster includes Rainer Blair (EVP), Daniel Comas (EVP), William Daniel (EVP), Brian Ellis (SVP), Linda Filler (Director), Jose-Carlos Gutierrez-Ramos (SVP), Linda Hefner (Director), Jennifer Honeycutt (EVP), Thomas Joyce, Jr. (CEO), William King (SVP), Angela Lalor (SVP), Angela Lalor (SVP), Teri List (Director), Walter Lohr (Director), Robert Lutz (CAO), Matthew McGrew (CFO), Mitchell Rales (Chairman), Daniel Raskas (SVP), John Schwieters (Director), Alan Spoon (Director), Raymond Stevens (Director), Joakim Weidemanis (EVP), and Elias Zerhouni (Director). Learn More on Danaher's active insiders.

Are insiders buying or selling shares of Danaher?

In the last twelve months, insiders at the conglomerate sold shares 14 times. They sold a total of 115,345 shares worth more than $28,921,815.03. The most recent insider tranaction occured on February, 26th when SVP Daniel Raskas sold 23,757 shares worth more than $5,986,764.00. Insiders at Danaher own 11.1% of the company. Learn More about insider trades at Danaher.

Information on this page was last updated on 2/26/2024.

Angela S. Lalor Insider Trading History at Danaher

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/29/2021Sell37,513$327.00$12,266,751.00View SEC Filing Icon  
4/23/2021Sell3,092$255.79$790,902.6830,937View SEC Filing Icon  
2/12/2021Sell6,437$244.70$1,575,133.9025,148View SEC Filing Icon  
8/31/2020Sell77,909$205.50$16,010,299.5052,445View SEC Filing Icon  
8/28/2020Sell38,954$205.00$7,985,570.0052,445View SEC Filing Icon  
2/3/2020Sell18,267$161.49$2,949,937.8356,782View SEC Filing Icon  
7/23/2019Sell20,000$142.30$2,846,000.0058,515View SEC Filing Icon  
5/16/2019Sell3,091$132.23$408,722.9338,515View SEC Filing Icon  
2/27/2019Sell4,534$127.25$576,951.5021,209View SEC Filing Icon  
2/2/2018Sell42,988$102.29$4,397,242.5282,008View SEC Filing Icon  
5/23/2017Sell10,815$84.16$910,190.4039,020View SEC Filing Icon  
5/12/2016Sell8,392$97.77$820,485.8448,110View SEC Filing Icon  
5/28/2015Sell5,959$87.06$518,790.54View SEC Filing Icon  
10/29/2014Sell8,450$79.45$671,352.50View SEC Filing Icon  
See Full Table

Angela S. Lalor Buying and Selling Activity at Danaher

This chart shows Angela S Lalor's buying and selling at Danaher by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Danaher Company Overview

Danaher logo
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.
Read More

Today's Range

Now: $248.84
Low: $247.09
High: $250.23

50 Day Range

MA: $246.68
Low: $224.58
High: $256.19

2 Week Range

Now: $248.84
Low: $182.09
High: $259.00

Volume

2,665,332 shs

Average Volume

2,769,566 shs

Market Capitalization

$184.07 billion

P/E Ratio

38.94

Dividend Yield

0.39%

Beta

0.84